| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/11/2002 | DE10064195A1 Verwendung einer Zusammensetzung zur Stimulation des Nervenwachstums, zur Inhibition der Narbengewebsbildung und/oder Reduktion eines Sekundärschadens Use of a composition for the stimulation of nerve growth, to inhibition of scar tissue formation and / or reduction of secondary damage |
| 07/11/2002 | CA2789161A1 Pharmaceutical composition to prevent tissue damage due to arterial blood flow failure |
| 07/11/2002 | CA2435483A1 Use as medicine of a compound restoring active principles in vivo |
| 07/11/2002 | CA2434136A1 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 07/11/2002 | CA2434072A1 Regulation of organic nitrate tolerance |
| 07/11/2002 | CA2433828A1 Novel estrogen receptor ligands and methods i |
| 07/11/2002 | CA2433782A1 Proteins and nucleic acids encoding same |
| 07/11/2002 | CA2433580A1 Tertiary perfluorocycloamines as a basis for gas transport emulsions and process for preparing thereof |
| 07/11/2002 | CA2433573A1 Alkanoic acid derivatives, process for their production and use thereof |
| 07/11/2002 | CA2433446A1 Inhibitors of memapsin 2 and use thereof |
| 07/11/2002 | CA2433263A1 Stabilized pharmaceutical composition in lyophilized form |
| 07/11/2002 | CA2433174A1 Cholesterol biosynthesis inhibitor containing tricyclic compound having spiro union as effective component |
| 07/11/2002 | CA2433041A1 Use of intermediate-conductance potassium channels and modulators for diagnosing and treating diseases involving disturbed keratinocyte activiyty |
| 07/11/2002 | CA2432959A1 Sodium channel modulators derived from 2-piperidylimidazoles |
| 07/11/2002 | CA2432853A1 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 07/11/2002 | CA2432504A1 Methods and compositions for treating periodontal disease |
| 07/11/2002 | CA2432409A1 Tropolone derivative |
| 07/11/2002 | CA2432184A1 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
| 07/11/2002 | CA2431545A1 Excitatory amino acid receptor antagonists |
| 07/11/2002 | CA2431413A1 Stable skin conditioning compositions containing retinoid boosters |
| 07/11/2002 | CA2430667A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/10/2002 | EP1221615A2 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy |
| 07/10/2002 | EP1221490A2 Recombinant adenoviral vectors and their utilization in the treatment of various types of hepatic, renal and pulmonary fibrosis and hypertrophic scars |
| 07/10/2002 | EP1221484A2 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 07/10/2002 | EP1221480A1 Polypeptide humanin inhibiting nerve cell death |
| 07/10/2002 | EP1221477A2 Transfection of vertebrate cells e.g. by homologous recombination |
| 07/10/2002 | EP1221444A1 Fused imidazole compounds and remedies for diabetes mellitus |
| 07/10/2002 | EP1221441A2 LTA4 Hydrolase inhibitors |
| 07/10/2002 | EP1221440A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
| 07/10/2002 | EP1221439A1 Tetrahydroquinoline derivatives |
| 07/10/2002 | EP1221326A2 Nitric oxide donors capable of reducing toxicity from drugs |
| 07/10/2002 | EP1221315A1 Ophthalmic adhesive preparations for percutaneous absorption |
| 07/10/2002 | EP1220934A2 Methods for making recombinant proteins using apoptosis inhibitors |
| 07/10/2002 | EP1220931A1 Dna encoding prost 07 polypeptide |
| 07/10/2002 | EP1220929A1 Human ubiquitin protease |
| 07/10/2002 | EP1220921A1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 07/10/2002 | EP1220920A1 The prv-1 gene and use thereof |
| 07/10/2002 | EP1220917A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 07/10/2002 | EP1220911A2 P-glycoproteins and uses thereof |
| 07/10/2002 | EP1220909A2 Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors |
| 07/10/2002 | EP1220902A2 Conjugates between a peptide and a nucleic acid analog, such as a pna, lna or a morpholino |
| 07/10/2002 | EP1220901A1 26 human secreted proteins |
| 07/10/2002 | EP1220872A1 Uroguanylin as an intestinal cancer inhibiting agent |
| 07/10/2002 | EP1220869A1 Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |
| 07/10/2002 | EP1220865A1 43 human secreted proteins |
| 07/10/2002 | EP1220862A1 Purine derivatives |
| 07/10/2002 | EP1220858A2 Oxazinoquinolones useful for the treatment of viral infections |
| 07/10/2002 | EP1220857A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/10/2002 | EP1220856A2 Pyrazolo[4,3-d]pyrimidine derivatives |
| 07/10/2002 | EP1220854A2 Novel tropane analogs |
| 07/10/2002 | EP1220853A1 Piperidine derivatives as serotonine reuptake inhibitors |
| 07/10/2002 | EP1220852A1 Substituted diazepans |
| 07/10/2002 | EP1220845A1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors |
| 07/10/2002 | EP1220844A1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors |
| 07/10/2002 | EP1220843A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 07/10/2002 | EP1220842A1 Cyclic amine compounds as ccr5 antagonists |
| 07/10/2002 | EP1220840A2 Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
| 07/10/2002 | EP1220836A2 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 07/10/2002 | EP1220832A1 Novel aromatic compounds |
| 07/10/2002 | EP1220689A2 Treatment of fatigue, head injury and stroke |
| 07/10/2002 | EP1220684A2 Methods related to immunostimulatory nucleic acid-induced interferon |
| 07/10/2002 | EP1220682A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 07/10/2002 | EP1220680A2 Echinacea supplement and method of manufacture |
| 07/10/2002 | EP1220669A1 Therapeutic intervention to mimic the effect of caloric restriction |
| 07/10/2002 | EP1220661A2 Transdermal therapeutic system for administering acetylsalicylic acid and/or salicylic acid |
| 07/10/2002 | EP1220617A1 Fish feed with increased nucleotide content |
| 07/10/2002 | EP1140786A4 Reductive alkylation of secondary amines with hydrosilane |
| 07/10/2002 | EP1073451B1 Deltorphine for treating ischemia |
| 07/10/2002 | EP0914158B1 Pharmaceutical combination containing a compound having angiotensin ii antagonistic activity and a compound which increases the insulin-sensitivity |
| 07/10/2002 | EP0812319B1 2-arylbenzazole compounds |
| 07/10/2002 | EP0679088B1 Pulmonary delivery of active fragments of parathyroid hormone |
| 07/10/2002 | EP0517852B1 Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists |
| 07/10/2002 | CN1358197A Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 07/10/2002 | CN1358195A Inhibitors of integrin alpha V beta 6 |
| 07/10/2002 | CN1358191A N-pyrazole A2A receptor agonists |
| 07/10/2002 | CN1358190A Propargyl phenyl ether A2A receptor agonists |
| 07/10/2002 | CN1358187A New compounds |
| 07/10/2002 | CN1358182A 呼吸道合胞病毒复制抑制剂 Respiratory syncytial virus replication inhibitors |
| 07/10/2002 | CN1358181A 呼吸道合胞病毒复制抑制剂 Respiratory syncytial virus replication inhibitors |
| 07/10/2002 | CN1358179A Thiazole and oxazole derivatives and their pharmaceutical use |
| 07/10/2002 | CN1358178A Pharmaceutical compounds |
| 07/10/2002 | CN1358175A Pyrimidinone compounds |
| 07/10/2002 | CN1358174A New Compounds |
| 07/10/2002 | CN1358169A N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| 07/10/2002 | CN1358104A Low dose estrogen interupted hormone replacement therapy |
| 07/10/2002 | CN1358096A Remedies for diabetes |
| 07/10/2002 | CN1358094A Method for treating chronic pain using MEK inhibitors |
| 07/10/2002 | CN1357620A Hemapoietic stem/ancestral cell enriching method and its in vitro directional induction and differentiation |
| 07/10/2002 | CN1357375A Cardiac and cerebral blood-supply decoction |
| 07/10/2002 | CN1357354A Medicine for eliminating side effect of radiotherapy and chemotherapy to treat malignant tumor and its prepn |
| 07/10/2002 | CN1357350A Oral prepn for eliminating bad body smells |
| 07/10/2002 | CN1357334A Artificial bear bile powder |
| 07/10/2002 | CN1357327A Carbazolyl alkaloid anticarcinogen and its prepn |
| 07/10/2002 | CN1357325A Prepn of natural active body cell multiplication promoter |
| 07/10/2002 | CN1357268A Beverage capable of depressing blood pressure and clearing away internal heat |
| 07/10/2002 | CN1357243A Health milk and milk product containing rich ganglioside and their application |
| 07/10/2002 | CN1087344C Transforming growth factor alpha-H1 |
| 07/10/2002 | CN1087288C Crystalline [R-(R+,R+)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(5-methylethyl)-3-phenyl-4-(phenylamino) carbonyl]-1H-pyrole-1-heptanoic acid hemi-calcium salt (atorvastatin) |
| 07/10/2002 | CN1087168C Compound with cooperation of anti-malaria |
| 07/09/2002 | US6417393 Treatment of sickle-cell anemia, brain edema from tumors or ischemia, diarrhea, and glaucoma; hypotensive, wound healing, antiinflammatory and antiallergen agents |